The utility of antibodies as reagents is of paramount importance in research, diagnosis, and clinical development.
Antibodies, both polyclonal and monoclonal, are well established and versatile reagent tools for the study of a wide variety of biological functions and quantification of a host of analytes.
Our white paper "Antibody Optimization" offers key opinions on the production of antibodies to support the development of reagents for basic research, diagnostics, therapeutic products.
They are also used as therapeutic drugs in their own right and are amongst the biggest selling therapeutics making significant difference to patients’ lives.
This white paper reviews the use of antibodies in the development of therapeutic products. In “Antibody optimization:”
- Discover how careful planning and consideration can affect the quality of an antibody
- Discuss what other factors affect performance and how to mitigate against them
- Learn what the key considerations for the generation and large scale production of high-quality, optimized antibodies are and their impact
Complete the form to read our white paper.